ConductScience.org, home

Paper17513723

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

Näslund TI and 7 others. J Immunol, 2007. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor. Papers, record 17513723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513723

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
PubMed
Journal
J Immunol
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2021-01-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Näslund TITanja I
2Uyttenhove CCatherine
3Nordström EKEva K L
4Colau DDidier
5Warnier GGuy
6Jondal MMikael
7Van den Eynde BJBenoît J
8Liljeström PPeter

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenoviridaeMajor topic
Canarypox virusMajor topic
Cancer VaccinesMajor topic
Immunization, SecondaryMajor topic
Immunologic MemoryMajor topic
Semliki forest virusMajor topic
T-Lymphocytes, CytotoxicMajor topic
Viral VaccinesMajor topic
Animals
Antigens, Neoplasm
Cell Line, Tumor
Epitopes, T-Lymphocyte
Female
Genetic Vectors
Leukemia L1210
Mastocytoma
Mice
Mice, Inbred DBA
Mice, Mutant Strains

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
39384196Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.J Immunother Cancer2024https://conductscience.org/library/papers/39384196PubMed
37834397Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.Int J Mol Sci2023https://conductscience.org/library/papers/37834397PubMed
34479921Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.J Immunother Cancer2021https://conductscience.org/library/papers/34479921PubMed
33637600TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.J Immunother Cancer2021https://conductscience.org/library/papers/33637600PubMed
33322641Current Advances in Burkholderia Vaccines Development.Cells2020https://conductscience.org/library/papers/33322641PubMed
31292532Optimizing oncolytic virotherapy in cancer treatment.Nat Rev Drug Discov2019https://conductscience.org/library/papers/31292532PubMed
30546947Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.Oncoimmunology2019https://conductscience.org/library/papers/30546947PubMed
30524901Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.Oncoimmunology2018https://conductscience.org/library/papers/30524901PubMed
30465060An alphavirus-based therapeutic cancer vaccine: from design to clinical trial.Cancer Immunol Immunother2019https://conductscience.org/library/papers/30465060PubMed
30288352Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens.Oncoimmunology2018https://conductscience.org/library/papers/30288352PubMed
30135181Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.J Immunol2018https://conductscience.org/library/papers/30135181PubMed
29205929Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.Immun Inflamm Dis2018https://conductscience.org/library/papers/29205929PubMed
29123081Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.Nat Commun2017https://conductscience.org/library/papers/29123081PubMed
28918040Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.Mol Ther Nucleic Acids2017https://conductscience.org/library/papers/28918040PubMed
28751892Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.Front Immunol2017https://conductscience.org/library/papers/28751892PubMed
27119097Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.Mol Ther Oncolytics2015https://conductscience.org/library/papers/27119097PubMed
26161423Human Tumor Antigens and Cancer Immunotherapy.Biomed Res Int2015https://conductscience.org/library/papers/26161423PubMed
26139534Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.EMBO J2015https://conductscience.org/library/papers/26139534PubMed
25122792Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.J Virol2014https://conductscience.org/library/papers/25122792PubMed
25001465Therapeutic vaccines for cancer: an overview of clinical trials.Nat Rev Clin Oncol2014https://conductscience.org/library/papers/25001465PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17513723

GET https://conductscience.org/api/papers/v1/17513723/cited_by?page=2